Lista de obras -

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3

scientific journal article

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results

artículo científico publicado en 2012

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

artículo científico publicado en 2007

Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth

artículo científico publicado en 2009

Assessing the quality of studies on the diagnostic accuracy of tumor markers ⬇️

artículo científico publicado en 2014

Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells

artículo científico publicado en 2012

CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer.

artículo científico publicado en 2017

Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.

artículo científico publicado en 2010

Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort

artículo científico publicado en 2009

Chemoprevention of bladder cancer

artículo científico publicado en 2002

Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy

artículo científico publicado en 2003

Clinical outcomes of cT1 micropapillary bladder cancer

artículo científico publicado en 2014

Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base

artículo científico publicado en 2014

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

artículo científico publicado en 2014

Converging Roads to Early Bladder Cancer

scientific article published on 17 March 2020

Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9].

artículo científico publicado en 2015

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

artículo científico publicado en 2020

Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder

artículo científico publicado en 2011

Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers

artículo científico publicado en 2009

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).

artículo científico publicado en 2013

Current concepts--future needs: the 10th Annual Meeting of the International Bladder Cancer Network (IBCN) in Nijmegen, The Netherlands, September 20th to 22nd, 2012.

artículo científico publicado en 2014

Current state of immunotherapy for bladder cancer

artículo científico publicado en 2004

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

artículo científico publicado en 2015

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort

scientific article published on 18 January 2011

Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails

artículo científico publicado en 2019

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?

artículo científico publicado en 2012

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

scientific article published on 19 November 2019

Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis

artículo científico publicado en 2014

Focus on bladder cancer

artículo científico publicado en 2004

Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations

artículo científico publicado en 2016

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer

artículo científico publicado en 2010

Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk

artículo científico publicado en 2012

Genome-wide association study identifies multiple loci associated with bladder cancer risk

artículo científico publicado en 2014

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers

artículo científico

Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry

artículo científico publicado en 2016

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

artículo científico publicado en 2014

Innovation in Bladder Cancer Immunotherapy

artículo científico publicado en 2016

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

artículo científico publicado en 2010

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

artículo científico publicado en 2008

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines

artículo científico publicado en 2016

Micropapillary bladder cancer: current treatment patterns and review of the literature.

artículo científico publicado en 2014

Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms

artículo científico publicado en 2015

Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma

artículo científico publicado en 2014

Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies

artículo científico publicado en 2015

Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study

artículo científico publicado en 2018

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy ⬇️

artículo científico publicado el 26 de febrero de 2011

Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.

artículo científico publicado en 2017

Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.

artículo científico publicado en 2017

Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review

artículo científico publicado en 2016

Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors

artículo científico publicado en 2004

Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer

artículo científico publicado en 2004

RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program

artículo científico publicado en 2017

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

artículo científico publicado en 2013

Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.

artículo científico publicado en 2018

Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists ⬇️

artículo científico publicado el 24 de abril de 2012

Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells

artículo científico publicado en 2015

Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment

scientific article published on 20 September 2020

Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL ⬇️

artículo científico publicado el 18 de abril de 2012

Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration

artículo científico publicado en 2017

Strategies to minimize readmission rates following major urologic surgery

artículo científico publicado en 2017

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

artículo científico publicado en 2017

The role of radical cystectomy in patients with clinical T4b bladder cancer

artículo científico publicado en 2010

Treatment of muscle-invasive bladder cancer: progress and new challenges

artículo científico publicado en 2004

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial ⬇️

artículo científico publicado el 15 de enero de 2012

Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer

artículo científico publicado en 2014

What Is the Significance of Variant Histology in Urothelial Carcinoma?

artículo científico publicado en 2019

ZKSCAN3 is a master transcriptional repressor of autophagy

artículo científico publicado en 2013

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results

Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy

Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth

Assessing the quality of studies on the diagnostic accuracy of tumor markers ⬇️

Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells

CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer.

Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy.

Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort

Chemoprevention of bladder cancer

Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy

Clinical outcomes of cT1 micropapillary bladder cancer

Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

Converging Roads to Early Bladder Cancer

Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9].

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder

Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers

Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS).

Current concepts--future needs: the 10th Annual Meeting of the International Bladder Cancer Network (IBCN) in Nijmegen, The Netherlands, September 20th to 22nd, 2012.

Current state of immunotherapy for bladder cancer

Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort

Do Not Learn a Technique, Learn the Biology Underlying the Disease: Techniques Evolve, Biology Prevails

Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis

Focus on bladder cancer

Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations

Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer

Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk

Genome-wide association study identifies multiple loci associated with bladder cancer risk

ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, diagnosis, and molecular markers

Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

Innovation in Bladder Cancer Immunotherapy

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines

Micropapillary bladder cancer: current treatment patterns and review of the literature.

Mitochondrial DNA Content as Risk Factor for Bladder Cancer and Its Association with Mitochondrial DNA Polymorphisms

Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma

Novel fluorescence in situ hybridization-based definition of bacille Calmette-Guérin (BCG) failure for use in enhancing recruitment into clinical trials of intravesical therapies

Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study

Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy ⬇️

Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.

Proceedings of the 3rd Annual Albert Institute for Bladder Cancer Research Symposium.

Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review

Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors

Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer

RalBP1 and p19-VHL play an oncogenic role, and p30-VHL plays a tumor suppressor role during the blebbishield emergency program

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic Review.

Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists ⬇️

Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells

Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment

Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL ⬇️

Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration

Strategies to minimize readmission rates following major urologic surgery

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

The role of radical cystectomy in patients with clinical T4b bladder cancer

Treatment of muscle-invasive bladder cancer: progress and new challenges

Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial ⬇️

Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer

What Is the Significance of Variant Histology in Urothelial Carcinoma?

ZKSCAN3 is a master transcriptional repressor of autophagy